Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age4-9
SponsorCairo University
About this trial
The present study aims to evaluate the clinical and radiographic success of pulpotomy using 3Mixtatin versus pulpectomy using Metapex in primary molars with irreversible pulpitis in children aged 4 to 9 years.
Eligibility criteria
Qualifiers
Children aged from 4 to 9 years with vital primary molars showing signs of irreversible pulpitis.
Children with spontaneous pain lasting a few seconds to several hours.
Pain is intensified by thermal stimulus and persists after its removal.
Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.
Disqualifiers
Unrestorable primary molars.
Primary molars with uncontrolled pulp hemorrhage or pulp necrosis.
Medically compromised patients who have systemic disease.
Uncooperative children who refuse treatment.
Trial design
Treatments tested in this trial
- Metapex
- 3Mixtatin
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov